Skip to content

Effect of Ultrasound-guided Interscalene Brachial Plexus Block Using Liposome Bupivacaine Combined with Continuous Esketamine Infusion on Quality of Recovery in Patients Undergoing Arthroscopic Rotator Cuff Repair: Protocol of a Prospective Randomized Double-blind Placebo-Controlled Trial

Effect of Ultrasound-guided Interscalene Brachial Plexus Block Using Liposome Bupivacaine Combined with Continuous Esketamine Infusion on Quality of Recovery in Patients Undergoing Arthroscopic Rotator Cuff Repair: Protocol of a Prospective Randomized Double-blind Placebo-Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500112854
Enrollment
Unknown
Registered
2025-11-20
Start date
2025-12-10
Completion date
Unknown
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rotator cuff tear

Interventions

Control group:Continuous intraoperative infusion of equal volume of normal saline
Intervention group:Ultrasound-guided Interscalene Brachial Plexus Block Using Liposome Bupivacaine Combined with Continuous Esketamine Infusion

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >= 18 years old; 2. American Society of Anesthesiologists (ASA) Physical Status Classification I-III; 3. Scheduled for elective ARCR surgery under general anesthesia; 4. Signed the informed consent form, and be able to understand and cooperate with the study protocol as well as complete follow-up visits.

Exclusion criteria

Exclusion criteria: 1. History of central nervous system diseases, peripheral neuropathy, or cervical spine diseases; 2. History of chronic pain syndrome; 3. History of allergy or contraindication to any of the study medications; 4. History of severe respiratory system diseases; 5. Presence of mental illness or cognitive impairment; 6. History of drug or alcohol abuse, or long-term use of opioids; 7. Contraindication to interscalene nerve block; 8. Pregnancy or plans for childbearing within 6 months after surgery; 9. Planned admission to the intensive care unit (ICU) postoperatively; 10. Participation in other clinical trials of drugs or medical devices within the past 3 months.

Design outcomes

Primary

MeasureTime frame
15-item Quality of Recovery scale;

Secondary

MeasureTime frame
Total opioid consumption;Incidence of adverse reactions;Severity of recovery classification;Sleep quality score;Frequency and time of rescue analgesia;Postoperative delirium;Postoperative pain score and the area under the curve;Total hospitalization cost;15-item Quality of Recovery scale;Intraoperative period and during postoperative hospitalization;Pain interference scores;Postoperative anxiety and depression scores;The area under the curve of 15-item Quality of Recovery scale;

Countries

China

Contacts

Public ContactZhou Leng

West China Hospital of Sichuan University

zhoulenghx@foxmail.com+86 18980601585

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 15, 2026